Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume

Abstract Background To manage the anemic status in hemodialysis (HD) patients, a well-balanced combination therapy based on the use of erythropoiesis-stimulating agents (ESAs) and iron supplementation is essential. Serum ferritin level and transferrin saturation rate (TSAT) are the current standard...

Full description

Bibliographic Details
Main Authors: Kumiko Onda, Teruo Koyama, Sanae Kobayashi, Yoji Ishii, Kazuo Ohashi
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Renal Replacement Therapy
Subjects:
MCV
Online Access:https://doi.org/10.1186/s41100-021-00327-x